Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Among them, one peptide in particular has caught the attention of the performance optimization world: BPC-157
Frenkel MY, Bear MF (2004)
Neither were published and Pliva was so excited about the results it abandoned the drug entirely One Phase I safety and pharmacokinetics trial of oral BPC-157, registered in 2015, that has no public results and appears to have been withdrawn or abandoned Three small and nonrandomized uncontrolled pilot studies from a single for-profit clinic in Florida, which included a 16-patient knee-pain chart review, a 12-woman interstitial cystitis study, and a small intravenous safety study One legitimate entry: a registered Phase 2 trial of BPC-157 for acute hamstring strain
These therapeutic peptides are being studied for their ability to cross the blood-brain barrier, support neural repair, improve synaptic communication, and reduce oxidative stress and inflammation key contributors to brain degeneration
US$ 25.03
US$ 21.76
US$ 24.49
US$ 20.25